NADPH Oxidase-Derived ROS Signaling and Therapeutic Opportunities

Curr Pharm Des. 2015;21(41):5931-2. doi: 10.2174/1381612822999151105125230.

Author

Hitesh Peshavariya¹

Affiliation

¹ Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital Level 1, 32 Gisborne Street EAST MELBOURNE VIC 3002. Hitesh.peshavariya@unimelb.edu.au.

PMID: 26537745
DOI: 10.2174/1381612822999151105125230

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Cardiovascular Diseases / drug therapy
Cardiovascular Diseases / metabolism
Diabetes Mellitus / drug therapy
Diabetes Mellitus / metabolism
Enzyme Inhibitors / pharmacology*
Enzyme Inhibitors / therapeutic use*
Fibrosis / drug therapy
Fibrosis / metabolism
Humans
NADPH Oxidases / antagonists & inhibitors*
NADPH Oxidases / genetics
NADPH Oxidases / metabolism*
Neoplasms / drug therapy
Neoplasms / metabolism
Reactive Oxygen Species / metabolism*
Retinal Diseases / drug therapy
Retinal Diseases / metabolism
Signal Transduction / drug effects*

Substances

Enzyme Inhibitors
Reactive Oxygen Species
NADPH Oxidases